Series B - Onconano Medicine
Investment Firm
Overview
OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.
Announced Date
Jun 17, 2021
Funding Type
Series B
Highlights
Location
United States, North America
Social
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
Onconano Medicine raised $50000000 on 2021-06-17 in Series B
OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 17, 2021 |  Series B - Onconano Medicine | 2 | - | 50.0M |
| Oct 25, 2021 | Series B - Onconano Medicine | 1 | - | 18.4M |
| Oct 02, 2021 | Convertible Note - Onconano Medicine | 1 | - | 68.4M |
| Dec 22, 2016 | Grant - Onconano Medicine | 1 | - | 6.0M |
Recent Activity
There is no recent news or activity for this profile.